Literature DB >> 6505042

First use of GdDTPA/dimeglumine in man.

M Laniado, H J Weinmann, W Schörner, R Felix, U Speck.   

Abstract

The dimeglumine salt of the Gd-DTPA complex has a strong paramagnetic effect and a very low toxicity in animals. This report of its use in human volunteers confirms its low toxicity and indicates its usefulness in the enhancement of signal intensity of the kidney and bladder.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6505042

Source DB:  PubMed          Journal:  Physiol Chem Phys Med NMR        ISSN： 0748-6642


  10 in total

1.  Analysis of pharmacokinetics of Gd-DTPA for dynamic contrast-enhanced magnetic resonance imaging.

Authors:  Saeid Taheri; N Jon Shah; Gary A Rosenberg
Journal:  Magn Reson Imaging       Date:  2016-04-22       Impact factor: 2.546

2.  Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

Authors:  Houshang Amiri; Mangala Srinivas; Andor Veltien; Mark J van Uden; I Jolanda M de Vries; Arend Heerschap
Journal:  Eur Radiol       Date:  2014-11-06       Impact factor: 5.315

Review 3.  A Review of the Current Evidence on Gadolinium Deposition in the Brain.

Authors:  Richard Pullicino; Mark Radon; Shubhabrata Biswas; Maneesh Bhojak; Kumar Das
Journal:  Clin Neuroradiol       Date:  2018-03-09       Impact factor: 3.649

4.  Diagnostic role of gadolinium-DTPA in pediatric neuroradiology. A retrospective review of 655 cases.

Authors:  H L Ge; W L Hirsch; G L Wolf; R A Rubin; R K Hackett
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 5.  Breast cancer imaging: a perspective for the next decade.

Authors:  Andrew Karellas; Srinivasan Vedantham
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

6.  Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.

Authors:  D Balériaux; C Matos; D De Greef
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

7.  Gadolinium-DTPA as a contrast agent in magnetic resonance imaging of the brain.

Authors:  J P Stack; N M Antoun; J P Jenkins; R Metcalfe; I Isherwood
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

Review 8.  Ten Things You Might Not Know about Iron Oxide Nanoparticles.

Authors:  Heike E Daldrup-Link
Journal:  Radiology       Date:  2017-09       Impact factor: 11.105

Review 9.  25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives.

Authors:  Jessica Lohrke; Thomas Frenzel; Jan Endrikat; Filipe Caseiro Alves; Thomas M Grist; Meng Law; Jeong Min Lee; Tim Leiner; Kun-Cheng Li; Konstantin Nikolaou; Martin R Prince; Hans H Schild; Jeffrey C Weinreb; Kohki Yoshikawa; Hubertus Pietsch
Journal:  Adv Ther       Date:  2016-01-25       Impact factor: 3.845

Review 10.  Molecular MRI of atherosclerosis.

Authors:  Alkystis Phinikaridou; Marcelo E Andia; Sara Lacerda; Silvia Lorrio; Marcus R Makowski; René M Botnar
Journal:  Molecules       Date:  2013-11-13       Impact factor: 4.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.